Examkin

Soru

Zorluk: OrtaDepressive Disorders

Review the clinical vignettes below, representing adult patients currently undergoing psychiatric evaluation for mood symptoms. Map each individual's unique presentation to the most appropriate initial pharmacological or procedural intervention.

  • A 42-year-old man hospitalized for profound despair, psychomotor agitation, and mood-congruent auditory hallucinations telling him he is 'corrupted from the inside.' He is medically stable, cooperative with nursing staff, and eating adequately.Combined antidepressant and antipsychotic pharmacotherapy
  • A 68-year-old man transferred from an assisted living facility due to a 10-day history of mutism, stupor, and absolute refusal to ingest food or fluids, which has now resulted in acute prerenal azotemia and severe dehydration.Electroconvulsive therapy (ECT)
  • A 24-year-old woman with a two-month history of sleeping 14 hours daily, intense carbohydrate cravings, weight gain, and 'leaden' fatigue. She strongly desires medication but specifically requests an option that avoids sexual side effects.Bupropion monotherapy
  • A 28-year-old woman presenting 4 weeks after an uncomplicated vaginal delivery with pervasive anhedonia, insomnia despite infant sleep, and extreme tearfulness. She is exclusively breastfeeding her newborn infant.Sertraline monotherapy

Cevap

The correct pairings map the medically stable psychotic depression to combined antidepressant/antipsychotic therapy; the life-threatening catatonic depression to ECT; the atypical depression with sexual side-effect concerns to bupropion; and the postpartum depression in a lactating mother to sertraline.
Each correct match strictly aligns with psychiatric treatment guidelines: psychotic features require dual therapy (antidepressant + antipsychotic); severe medical compromise (starvation/dehydration) mandates the rapid, definitive efficacy of ECT; atypical symptoms with an aversion to sexual dysfunction perfectly fit the profile for bupropion; and lactation requires medications with negligible breast milk excretion, like sertraline.

Adım Adım Çözüm

1
Analyze each patient's presenting symptoms to identify the specific depressive subtype or modifying clinical circumstance.
Identified psychotic features, life-threatening catatonia, atypical features with specific side-effect requests, and the postpartum/lactating state.
Major depressive disorder is heterogeneous; treatment choice heavily relies on recognizing these specific modifiers.
2
Select the evidence-based first-line treatment corresponding to each clinical modifier.
Matched each presentation to its respective guideline-directed therapy (e.g., ECT for acute life-threatening situations, Sertraline for lactation safety).
Ensures the chosen intervention maximizes efficacy while minimizing harm for the specific demographic or symptomatic presentation.

Anahtar Kavram

Treatment selection for major depressive disorder subtypes and special populations
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Depressive Disorders

Bu konudan daha fazla soru